Triple
T10292310
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | human adenovirus serotype 26 |
E241391
|
entity |
| Predicate | encodesInCOVID19Vaccine |
P14248
|
FINISHED |
| Object |
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
|
E854994
|
NE FINISHED |
How this triple was built (5 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: SARS-CoV-2 spike glycoprotein | Statement: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 spike glycoprotein Context triple: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
-
A.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
B.
REGN-COV2
REGN-COV2 is a monoclonal antibody cocktail designed to prevent and treat COVID-19 by targeting the SARS-CoV-2 virus.
-
C.
BNT162b2
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
-
D.
Omicron variant
The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
-
E.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: SARS-CoV-2 spike glycoprotein Triple: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
Generated description
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 spike glycoprotein Target entity description: The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
-
A.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
B.
REGN-COV2
REGN-COV2 is a monoclonal antibody cocktail designed to prevent and treat COVID-19 by targeting the SARS-CoV-2 virus.
-
C.
BNT162b2
BNT162b2 is an mRNA-based COVID-19 vaccine, co-developed by BioNTech and Pfizer, that became one of the first widely authorized vaccines against SARS-CoV-2.
-
D.
Omicron variant
The Omicron variant is a highly mutated and fast-spreading strain of the SARS-CoV-2 virus that caused major global surges in COVID-19 cases starting in late 2021.
-
E.
Omicron
Omicron is a vowel letter of the Greek alphabet, historically representing a short "o" sound and used today in various scientific and mathematical contexts.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: encodesInCOVID19Vaccine Context triple: [human adenovirus serotype 26, encodesInCOVID19Vaccine, SARS-CoV-2 spike glycoprotein]
-
A.
covid19VaccineType
Indicates the specific type or category of COVID-19 vaccine associated with an entity.
-
B.
encodes
chosen
Indicates that one entity contains or represents the information, instructions, or structure of another in a coded or symbolic form.
-
C.
vaccineUsed
Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
-
D.
encodedIn
Indicates that one entity is represented, stored, or expressed within another entity using a specific encoding or format.
-
E.
notEncodedIn
Indicates that a piece of information, data, or content is explicitly absent from or not represented within a given encoding, format, or medium.
- F. None of above.
Provenance (6 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d381aaafc08190af475ef58dc16aba |
completed | April 6, 2026, 9:49 a.m. |
| NER | Named-entity recognition | batch_69d4d2d35f048190a215493acdf1f718 |
completed | April 7, 2026, 9:48 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d71d1465e88190aaa8b295df3f9c8c |
completed | April 9, 2026, 3:29 a.m. |
| NEDg | Description generation | batch_69d73180d90481908f1b4768230edd36 |
completed | April 9, 2026, 4:56 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69d7326b14988190bff33dc01e690707 |
completed | April 9, 2026, 5 a.m. |
| PD | Predicate disambiguation | batch_69d4d1f35e548190be3b4d92d65d2d20 |
completed | April 7, 2026, 9:44 a.m. |
Created at: April 6, 2026, 11:42 a.m.